Brett Guthrie said...
H.R. 3, the drug pricing bill, is not the path forward.
Context
Guthrie argues against H.R. 3, claiming it jeopardizes innovation for neurodegenerative disease treatments.
07/28/2021
Guthrie argues against H.R. 3, claiming it jeopardizes innovation for neurodegenerative disease treatments.
07/28/2021